Dapagliflozin does not impair LDL catabolism and induces a shift towards a closer to normal VLDL1/VLDL2 catabolism in individuals with type 2 diabetes: a randomised in vivo kinetic study. - Vergès B; Rouland A; Bouillet B; Pais de Barros JP; Fourmont C; Buffier P; Jourdan T; Vergas V; Duvillard L (Diabetologia, 2026)